Statistics for Initial experience with brolucizumab for neovascular age-related macular degeneration (nAMD) in India – Multicentric, real-world study

Total visits

views
Initial experience with brolucizumab for neovascular age-related macular degeneration (nAMD) in India – Multicentric, real-world study 0

Total visits per month

views
June 2025 0
July 2025 0
August 2025 0
September 2025 0
October 2025 0
November 2025 0
December 2025 0